The DOI matches its Crossref record; 102 of the 102 references it cites were found in a registry or an index.
Epstein–Barr virus and Burkitt lymphoma
Open accessAbstract
Burkitt lymphoma (BL) is an aggressive B-cell malignancy with endemic, sporadic and immunodeficiency-associated variants. It has been known for many years that the fundamental transforming event in BL is the translocation of the MYC gene, and the events that bring about this translocation and those that allow cells to survive with the constitutive expression of MYC have been the subject of intense investigation. Epstein–Barr virus (EBV) infection, malaria, immunodeficiency and spontaneous, somatic mutation can all contribute to the origin and maintenance of this cancer and their mechanisms are the subject of this review.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The c-myc oncogene driven by immunoglobulin enhancers induces lymphoid malignancy in transgenic mice
Adams, J. M., Harris, A. W., Pinkert, C. A., Corcoran, L. M., Alexander, W. S., Cory, S., Palmiter, R. D., & Brinster, R. L. (1985) · Nature · doi:10.1038/318533a0 · Cited by 1,779
Max: A Helix-Loop-Helix Zipper Protein That Forms a Sequence-Specific DNA-Binding Complex with Myc
Blackwood, E. M., & Eisenman, R. N. (1991) · Science · doi:10.1126/science.2006410 · Cited by 1,697
Lane, H. C., Masur, H., Edgar, L. C., Whalen, G., Rook, A. H., & Fauci, A. S. (1983) · New England Journal of Medicine · doi:10.1056/nejm198308253090803 · Cited by 1,600
Pomerantz, J., Schreiber-Agus, N., Liégeois, N. J., Silverman, A., Alland, L., Chin, L., Potes, J., Chen, K., Orlow, I., Lee, H.-W., et al. (1998) · Cell · doi:10.1016/s0092-8674(00)81400-2 · Cited by 1,521
Ouelle, D. E., Zindy, F., Ashmun, R. A., & Sherr, C. J. (1995) · Cell · doi:10.1016/0092-8674(95)90214-7 · Cited by 1,485
Multiple Ras-dependent phosphorylation pathways regulate Myc protein stability
Sears, R., Nuckolls, F., Haura, E., Taya, Y., Tamai, K., & Nevins, J. R. (2000) · Genes & Development · doi:10.1101/gad.836800 · Cited by 1,393
mdm2 expression is induced by wild type p53 activity.
Barak, Y., Juven, T., Haffner, R., & Oren, M. (1993) · The EMBO Journal · doi:10.1002/j.1460-2075.1993.tb05678.x · Cited by 1,290
Myc signaling via the ARF tumor suppressor regulates p53-dependent apoptosis and immortalization
Zindy, F., Eischen, C. M., Randle, D. H., Kamijo, T., Cleveland, J. L., Sherr, C. J., & Roussel, M. F. (1998) · Genes & Development · doi:10.1101/gad.12.15.2424 · Cited by 1,245
Stott, F. J. (1998) · The EMBO Journal · doi:10.1093/emboj/17.17.5001 · Cited by 1,167
Bim: a novel member of the Bcl-2 family that promotes apoptosis
O'Connor, L. (1998) · The EMBO Journal · doi:10.1093/emboj/17.2.384 · Cited by 1,166
Epstein-Barr virus: exploiting the immune system
Thorley-Lawson, D. A. (2001) · Nature Reviews Immunology · doi:10.1038/35095584 · Cited by 939
Functional and physical interactions of the ARF tumor suppressor with p53 and Mdm2
Kamijo, T., Weber, J. D., Zambetti, G., Zindy, F., Roussel, M. F., & Sherr, C. J. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.14.8292 · Cited by 899
Gaidano, G., Ballerini, P., Gong, J. Z., Inghirami, G., Neri, A., Newcomb, E. W., Magrath, I. T., Knowles, D. M., & Dalla-Favera, R. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.12.5413 · Cited by 885
Coller, H. A., Grandori, C., Tamayo, P., Colbert, T., Lander, E. S., Eisenman, R. N., & Golub, T. R. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.7.3260 · Cited by 823
Disruption of the ARF-Mdm2-p53 tumor suppressor pathway in Myc-induced lymphomagenesis
Eischen, C. M., Weber, J. D., Roussel, M. F., Sherr, C. J., & Cleveland, J. L. (1999) · Genes & Development · doi:10.1101/gad.13.20.2658 · Cited by 819
Rowe, M., Rowe, D. T., Gregory, C. D., Young, L. S., Farrell, P. J., Rupani, H., & Rickinson, A. B. (1987) · The EMBO Journal · doi:10.1002/j.1460-2075.1987.tb02568.x · Cited by 711
Self-citationControl of c-myc Regulation in Normal and Neoplastic Cells
(1991) · Advances in Cancer Research · doi:10.1016/s0065-230x(08)60476-5 · Cited by 618
Adult Burkitt leukemia and lymphoma
Blum, K. A., Lozanski, G., & Byrd, J. C. (2004) · Blood · doi:10.1182/blood-2004-02-0405 · Cited by 579
Infection with HIV is associated with elevated IL-6 levels and production.
Breen, E. C., Rezai, A. R., Nakajima, K., Beall, G. N., Mitsuyasu, R. T., Hirano, T., Kishimoto, T., & Martinez-Maza, O. (1990) · The Journal of Immunology · doi:10.4049/jimmunol.144.2.480 · Cited by 578
Zindy, F., Quelle, D. E., Roussel, M. F., & Sherr, C. J. (1997) · Oncogene · doi:10.1038/sj.onc.1201178 · Cited by 574
Epstein–Barr Virus MicroRNAs Are Evolutionarily Conserved and Differentially Expressed
Cai, X., Schäfer, A., Lu, S., Bilello, J. P., Desrosiers, R. C., Edwards, R., Raab-Traub, N., & Cullen, B. R. (2006) · PLoS Pathogens · doi:10.1371/journal.ppat.0020023 · Cited by 559
A global transcriptional regulatory role for c-Myc in Burkitt's lymphoma cells
Li, Z., Van Calcar, S., Qu, C., Cavenee, W. K., Zhang, M. Q., & Ren, B. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1332764100 · Cited by 524
Gregory, M. A., & Hann, S. R. (2000) · Molecular and Cellular Biology · doi:10.1128/mcb.20.7.2423-2435.2000 · Cited by 469
Ras Enhances Myc Protein Stability
Sears, R., Leone, G., DeGregori, J., & Nevins, J. R. (1999) · Molecular Cell · doi:10.1016/s1097-2765(00)80308-1 · Cited by 460
Novel myc oncogene RNA from abortive immunoglobulin-gene recombination in mouse plasmacytomas
Shen-Ong, G. L. C., Keath, E. J., Piccoli, S. P., & Cole, M. D. (1982) · Cell · doi:10.1016/0092-8674(82)90137-4 · Cited by 454
Harvey, D. M., & Levine, A. J. (1991) · Genes & Development · doi:10.1101/gad.5.12b.2375 · Cited by 453
Evasion of the p53 tumour surveillance network by tumour-derived MYC mutants
Hemann, M. T., Bric, A., Teruya-Feldstein, J., Herbst, A., Nilsson, J. A., Cordon-Cardo, C., Cleveland, J. L., Tansey, W. P., & Lowe, S. W. (2005) · Nature · doi:10.1038/nature03845 · Cited by 452
Lyke, K. E., Burges, R., Cissoko, Y., Sangare, L., Dao, M., Diarra, I., Kone, A., Harley, R., Plowe, C. V., Doumbo, O. K., et al. (2004) · Infection and Immunity · doi:10.1128/iai.72.10.5630-5637.2004 · Cited by 434
Spatial proximity of translocation-prone gene loci in human lymphomas
Roix, J. J., McQueen, P. G., Munson, P. J., Parada, L. A., & Misteli, T. (2003) · Nature Genetics · doi:10.1038/ng1177 · Cited by 414
Burkitt's Lymphoma: Clinicopathologic Features and Differential Diagnosis
Ferry, J. A. (2006) · The Oncologist · doi:10.1634/theoncologist.11-4-375 · Cited by 377
ARTAVANIS-TSAKONAS, K., TONGREN, J. E., & RILEY, E. M. (2003) · Clinical and Experimental Immunology · doi:10.1046/j.1365-2249.2003.02174.x · Cited by 369
Shou, Y., Martelli, M. L., Gabrea, A., Qi, Y., Brents, L. A., Roschke, A., Dewald, G., Kirsch, I. R., Bergsagel, P. L., & Kuehl, W. M. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.1.228 · Cited by 347
Infectious agents and cancer: criteria for a causal relation
Pagano, J. S., Blaser, M., Buendia, M.-A., Damania, B., Khalili, K., Raab-Traub, N., & Roizman, B. (2004) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2004.06.009 · Cited by 337
Expression of Epstein-Barr virus nuclear antigen-1 induces B cell neoplasia in transgenic mice.
Wilson, J. B., Bell, J. L., & Levine, A. J. (1996) · The EMBO Journal · doi:10.1002/j.1460-2075.1996.tb00674.x · Cited by 334
Activation and somatic mutation of the translocated c-myc gene in Burkitt lymphoma cells
Taub, R., Moulding, C., Battey, J., Murphy, W., Vasicek, T., Lenoir, G. M., & Leder, P. (1984) · Cell · doi:10.1016/0092-8674(84)90227-7 · Cited by 331
Epstein–Barr virus RNA confers resistance to interferon‐α‐induced apoptosis in Burkitt's lymphoma
Nanbo, A., Inoue, K., Adachi‐Takasawa, K., & Takada, K. (2002) · The EMBO Journal · doi:10.1093/emboj/21.5.954 · Cited by 326
ar-Rushdi, A., Nishikura, K., Erikson, J., Watt, R., Rovera, G., & Croce, C. M. (1983) · Science · doi:10.1126/science.6414084 · Cited by 324
Eisenman, R. N. (2001) · Genes & Development · doi:10.1101/gad928101 · Cited by 319
Induction of IL-6 (B cell stimulatory factor-2/IFN-beta 2) production by HIV.
Nakajima, K., Martínez-Maza, O., Hirano, T., Breen, E. C., Nishanian, P. G., Salazar-Gonzalez, J. F., Fahey, J. L., & Kishimoto, T. (1989) · The Journal of Immunology · doi:10.4049/jimmunol.142.2.531 · Cited by 304
Rearrangements of the c-myc oncogene are present in 15% of primary human multiple myeloma tumors
Avet-Loiseau, H., Gerson, F., Magrangeas, F., Minvielle, S., Harousseau, J.-L., & Bataille, R. (2001) · Blood · doi:10.1182/blood.v98.10.3082 · Cited by 289
Biology and disease associations of Epstein–Barr virus
Crawford, D. H. (2001) · Philosophical Transactions of the Royal Society of London. Series B: Biological Sciences · doi:10.1098/rstb.2000.0783 · Cited by 285
T-cell control of Epstein–Barr virus-infected B cells is lost during P. falciparum malaria
Whittle, H. C., Brown, J., Marsh, K., Greenwood, B. M., Seidelin, P., Tighe, H., & Wedderburn, L. (1984) · Nature · doi:10.1038/312449a0 · Cited by 278
Epstein-Barr virus provides a survival factor to Burkitt's lymphomas
Kennedy, G., Komano, J., & Sugden, B. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2336099100 · Cited by 276
Oncogenic Role of Epstein-Barr Virus-Encoded RNAs in Burkitt’s Lymphoma Cell Line Akata
Komano, J. A., Maruo, S., Kurozumi, K., Oda, T., & Takada, K. (1999) · Journal of Virology · doi:10.1128/jvi.73.12.9827-9831.1999 · Cited by 268
Activation of a translocated human c-myc gene by an enhancer in the immunoglobulin heavy-chain locus
Hayday, A. C., Gillies, S. D., Saito, H., Wood, C., Wiman, K., Hayward, W. S., & Tonegawa, S. (1984) · Nature · doi:10.1038/307334a0 · Cited by 266
Neoteny in Lymphocytes: Rag1 and Rag2 Expression in Germinal Center B Cells
Han, S., Zheng, B., Schatz, D. G., Spanopoulou, E., & Kelsoe, G. (1996) · Science · doi:10.1126/science.274.5295.2094 · Cited by 263
Differential expression of the normal and of the translocated human c-myc oncogenes in B cells.
Nishikura, K., ar-Rushdi, A., Erikson, J., Watt, R., Rovera, G., & Croce, C. M. (1983) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.80.15.4822 · Cited by 256
p53 is frequently mutated in Burkitt's lymphoma cell lines
Farrell, P. J., Allan, G. J., Shanahan, F., Vousden, K. H., & Crook, T. (1991) · The EMBO Journal · doi:10.1002/j.1460-2075.1991.tb07837.x · Cited by 254
Self-citationPackham, G., & Cleveland, J. L. (1995) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/0304-419x(94)00015-t · Cited by 245
Kelly, G., Bell, A., & Rickinson, A. (2002) · Nature Medicine · doi:10.1038/nm758 · Cited by 228
Mutations in the First Exon Are Associated with Altered Transcription of c- myc in Burkitt Lymphoma
Cesarman, E., Dalla-Favera, R., Bentley, D., & Groudine, M. (1987) · Science · doi:10.1126/science.3685977 · Cited by 221
Reexpression of RAG-1 and RAG-2 Genes in Activated Mature Mouse B cells
Hikida, M., Mori, M., Takai, T., Tomochika, K.-I., Hamatani, K., & Ohmori, H. (1996) · Science · doi:10.1126/science.274.5295.2092 · Cited by 210
Kitagawa, N. (2000) · The EMBO Journal · doi:10.1093/emboj/19.24.6742 · Cited by 202
Persson, H., Hennighausen, L., Taub, R., DeGrado, W., & Leder, P. (1984) · Science · doi:10.1126/science.6431612 · Cited by 197
Rowe, M., Khanna, R., Jacob, C. A., Argaet, V., Kelly, A., Powis, S., Belich, M., Groom‐Carter, D., Lee, S., Burrows, S. R., et al. (1995) · European Journal of Immunology · doi:10.1002/eji.1830250536 · Cited by 191
Strobl, L. J., & Eick, D. (1992) · The EMBO Journal · doi:10.1002/j.1460-2075.1992.tb05409.x · Cited by 183
Haluska, F. G., Finver, S., Tsujimoto, Y., & Croce, C. M. (1986) · Nature · doi:10.1038/324158a0 · Cited by 178
Sharp, T. V., Schwemmle, M., Jeffrey, I., Laing, K., Mellor, H., Proud, C. G., Hilse, K., & Clemens, M. J. (1993) · Nucleic Acids Research · doi:10.1093/nar/21.19.4483 · Cited by 173
Epstein-Barr Virus (EBV) in Endemic Burkitt's Lymphoma: Molecular Analysis of Primary Tumor Tissue
Tao, Q., Robertson, K. D., Manns, A., Hildesheim, A., & Ambinder, R. F. (1998) · Blood · doi:10.1182/blood.v91.4.1373 · Cited by 166
The role of Epstein–Barr virus in cancer
Pattle, S. B., & Farrell, P. J. (2006) · Expert Opinion on Biological Therapy · doi:10.1517/14712598.6.11.1193 · Cited by 154
Self-citationMasood, R., Zhang, Y., Bond, M. W., Scadden, D. T., Moudgil, T. L., Law, R. E., Kaplan, M., Jung, B., Espina, B. M., & Lunardi-Iskandar, Y. (1995) · Blood · doi:10.1182/blood.v85.12.3423.bloodjournal85123423 · Cited by 150
Ogden, C. A., Pound, J. D., Batth, B. K., Owens, S., Johannessen, I., Wood, K., & Gregory, C. D. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.174.5.3015 · Cited by 147
Ruf, I. K., Rhyne, P., Yang, C., Cleveland, J. L., & Sample, J. T. (2000) · Journal of Virology · doi:10.1128/jvi.74.21.10223-10228.2000 · Cited by 138
Insertion of c- Myc into Igh Induces B-Cell and Plasma-Cell Neoplasms in Mice
Park, S. S., Kim, J. S., Tessarollo, L., Owens, J. D., Peng, L., Han, S. S., Chung, S. T., Torrey, T. A., Cheung, W. C., Polakiewicz, R. D., et al. (2005) · Cancer Research · doi:10.1158/0008-5472.can-04-0268 · Cited by 126
Circulating Epstein-Barr virus-carrying B cells in acute malaria
Lam, K. M. C., Syed, N., Crawford, D., & Whittle, H. (1991) · The Lancet · doi:10.1016/0140-6736(91)90203-2 · Cited by 122
Natkunam, Y. (2005) · Blood · doi:10.1182/blood-2004-08-3112 · Cited by 115
Chapman, C., Mockridge, C., Rowe, M., Rickinson, A. B., & Stevenson, F. K. (1995) · Blood · doi:10.1182/blood.v85.8.2176.bloodjournal8582176 · Cited by 113
p14ARF homozygous deletion or MDM2 overexpression in Burkitt lymphoma lines carrying wild type p53
Lindström, M. S., Klangby, U., & Wiman, K. G. (2001) · Oncogene · doi:10.1038/sj.onc.1204303 · Cited by 111
Gerondakis, S., Cory, S., & Adams, J. M. (1984) · Cell · doi:10.1016/0092-8674(84)90047-3 · Cited by 110
Distinctions between endemic and sporadic forms of epstein‐barr virus‐positive burkitt's lymphoma
Rowe, M., Rooney, C. M., Rickinson, A. B., Lenoir, G., Rupani, H., Moss, D. J., Stein, H., & Epstein, M. A. (1985) · International Journal of Cancer · doi:10.1002/ijc.2910350404 · Cited by 110
Moss, D. J., Burrows, S. R., Castelino, D., Kane, R. G., Pope, J. H., Rickinson, A. B., Alpers, M. P., & Heywood, P. (1983) · International Journal of Cancer · doi:10.1002/ijc.2910310609 · Cited by 109
Chapman, C., Zhou, J., Gregory, C. D., Rickinson, A. B., & Stevenson, F. K. (1996) · Blood · doi:10.1182/blood.v88.9.3562.bloodjournal8893562 · Cited by 105
A Point Mutation in the c- myc Locus of a Burkitt Lymphoma Abolishes Binding of a Nuclear Protein
Zajac‐Kaye, M., Gelmann, E. P., & Levens, D. (1988) · Science · doi:10.1126/science.2454510 · Cited by 101
Burkitt's lymphomas express VH genes with a moderate number of antigen-selected somatic mutations.
Tamaru, J., Hummel, M., Marafioti, T., Kalvelage, B., Leoncini, L., Minacci, C., Tosi, P., Wright, D. H., & Stein, H. (1995) · Europe PMC (PubMed Central) · Cited by 96
Burkitt’s lymphoma: new insights into molecular pathogenesis
Bellan, C., Lazzi, S., Falco, G. D., Nyongo, A., Giordano, A., & Leoncini, L. (2003) · Journal of Clinical Pathology · doi:10.1136/jcp.56.3.188 · Cited by 96
Circulating Epstein-Barr virus-carrying B cells in acute malaria
Lam, K. M. C. (1992) · Biomedicine & Pharmacotherapy · doi:10.1016/0753-3322(92)90070-n · Cited by 96
Donati, D., Mok, B. W.-Y., Chêne, A., Xu, H., Thangarajh, M., Glas, R., Chen, Q., Wahlgren, M., & Bejarano, M. T. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.177.5.3035 · Cited by 94
Khanna, R., Burrows, S. R., Argaet, V. P., & Moss, D. J. (1994) · International Immunology · doi:10.1093/intimm/6.4.639 · Cited by 92
Nanbo, A., Yoshiyama, H., & Takada, K. (2005) · Journal of Virology · doi:10.1128/jvi.79.19.12280-12285.2005 · Cited by 86
Ji, L., Arcinas, M., & Boxer, L. M. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.22.13392 · Cited by 83
Prendergast, G. C., & Ziff, E. B. (1992) · Trends in Genetics · doi:10.1016/0168-9525(92)90196-b · Cited by 81
Cinti, C., Leoncini, L., Nyong'o, A. O., Ferrari, F., Lazzi, S., Bellan, C., Vatti, R., Zamparelli, A., Cevenini, G., osi, G. M. T., et al. (2000) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)64941-3 · Cited by 77
Cinti, C., Claudio, P. P., Howard, C. M., Neri, L. M., Fu, Y., Leoncini, L., Tosi, G. M., Maraldi, N. M., & Giordano, A. (2000) · PubMed · Cited by 73
A human immunoglobulin gene reduces the incidence of lymphomas in c-Myc-bearing transgenic mice
Nussenzweig, M. C., Schmidt, E. V., Shaw, A. C., Sinn, E., Campos-Torres, J., Mathey-Prévôt, B., Pattengale, P. K., & Leder, P. (1988) · Nature · doi:10.1038/336446a0 · Cited by 73
Sarid, J., Halazonetis, T. D., Murphy, W., & Leder, P. (1987) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.84.1.170 · Cited by 72
Clybouw, C., Mchichi, B. E., Mouhamad, S., Auffredou, M., Bourgeade, M. F., Sharma, S., Leca, G., & Vázquez, A. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.175.5.2968 · Cited by 63
Dunnick, W. A., Shell, B. E., & Dery, C. (1983) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.80.23.7269 · Cited by 62
Leao, M., Anderton, E., Wade, M. R., Meekings, K. N., & Allday, M. J. (2006) · Journal of Virology · doi:10.1128/jvi.01096-06 · Cited by 60
Ji, L., Arcinas, M., & Boxer, L. M. (1994) · Molecular and Cellular Biology · doi:10.1128/mcb.14.12.7967-7974.1994 · Cited by 54
Haluska, F. G., Tsujimoto, Y., & Croce, C. M. (1987) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.84.19.6835 · Cited by 53
The effects ofPlasmodium falciparummalaria on immune control of B lymphocytes in Gambian children
Whittle, H., Brown, J. L., Marsh, K., Blackman, M. J., Jobe, O., & Shenton, F. C. (1990) · Clinical & Experimental Immunology · doi:10.1111/j.1365-2249.1990.tb05236.x · Cited by 53
Araújo, I., Foss, H., Hummel, M., Anagnostopoulos, I., Barbosa, H. S., Bittencourt, A. L., & Stein, H. (1999) · The Journal of Pathology · doi:10.1002/(sici)1096-9896(199902)187:3<326::aid-path242>3.0.co;2-n · Cited by 52
Ionov, Y., Le, X., Tunquist, B. J., Sweetenham, J. W., Sachs, T., Ryder, J., Johnson, T. R., Lilly, M. B., & Kraft, A. S. (2003) · PubMed · Cited by 48
Wilda, M., Busch, K., Klose, I., Keller, T., Woessmann, W., Kreuder, J. G., Harbott, J., & Borkhardt, A. (2004) · Genes Chromosomes and Cancer · doi:10.1002/gcc.20063 · Cited by 42
Lj, S., Kohlhuber, F., Mautner, J., et al. (1993) · PubMed · Cited by 37
Pear, W. S., Wahlström, G. M., Nelson, S. F., Axelson, H., Szeles, A., Wiener, F., Bazin, H., Klein, G., & Sümegi, J. (1988) · Molecular and Cellular Biology · doi:10.1128/mcb.8.1.441 · Cited by 36
Yu, B., Ichinose, I., Bonham, M. A., et al. (1993) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)36556-1 · Cited by 33
Clinical characteristics of Burkitt's lymphoma seen in Kenyan patients
Mwanda, O. (2004) · East African Medical Journal · doi:10.4314/eamj.v81i8.9211 · Cited by 33
Silva, S., Kovalchuk, A. L., Kim, J. S., Klein, G., & Janz, S. (2003) · PubMed · Cited by 32
The role of immunoglobulin kappa elements in c-myc activation.
Hörtnagel, K., Mautner, J., Lj, S., et al. (1995) · PubMed · Cited by 32
Ji, L., Arcinas, M., & Boxer, L. M. (1994) · Molecular and Cellular Biology · doi:10.1128/mcb.14.12.7967 · Cited by 32
A Biochemical and Biological Analysis of Myc Superfamily Interactions
Schreiber‐Agus, N., Alland, L., Muhle, R., Goltz, J. S., Chen, K., Stevens, L. M., Stein, D., & DePinho, R. A. (1997) · Current topics in microbiology and immunology · doi:10.1007/978-3-642-60801-8_16 · Cited by 7
Cited by
Epidemiology of Non-Hodgkin’s Lymphoma
Thandra, K. C., Barsouk, A., Saginala, K., Padala, S. A., Barsouk, A., & Rawla, P. (2021) · Medical Sciences · doi:10.3390/medsci9010005 · Cited by 386
Targeting ARID1A mutations in cancer
Mullen, J., Kato, S., Sicklick, J. K., & Kurzrock, R. (2021) · Cancer Treatment Reviews · doi:10.1016/j.ctrv.2021.102287 · Cited by 186
High-Throughput CRISPR Screening in Hematological Neoplasms
Ancos-Pintado, R., Bragado-García, I., Morales, M. L., García-Vicente, R., Arroyo-Barea, A., Rodríguez-García, A., Martínez-López, J., Linares, M., & Hernández-Sánchez, M. (2022) · Cancers · doi:10.3390/cancers14153612 · Cited by 15
Metadata
- Authors
- Brady, G., MacArthur, G. J., & Farrell, P. J.
- Venue
- Postgraduate Medical Journal
- Publisher
- Oxford University Press (OUP)
- Published
- 2008-07-01
- Volume
- 84
- Issue
- 993
- Pages
- 372-377
- ISSN
- 0032-5473 (ISSN-L)
- 1469-0756
- OpenAlex
- W1925065715
- Cited by
- 301
- References
- 102
- FWCI
- 6.04
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.